Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (271-280 of 365) with videos related to

Pageof 37
Sort By:
Epidemiology and Infection|August 10, 2021
SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospitalReinout Naesens, Helena Mertes, Johan Clukers, et al.
The Journal of Infectious Diseases|December 28, 2020
Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in BelgiumElizabeth B Brickley, Ruth I Connor, Wendy Wieland-Alter, et al.
Cell Host & Microbe|April 25, 2020
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceMing Te Yeh, Erika Bujaki, Patrick T Dolan, et al.
Vaccine|March 29, 2014
Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trialsPierre Van Damme, Geert Leroux-Roels, Philippe Simon, et al.
BMJ Global Health|June 29, 2021
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the CongoGwen Lemey, Ynke Larivière, Trésor Matuvanga Zola, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysisArno Verleye, Veerle Wijtvliet, Steven Abrams, et al.
Vaccine|January 1, 2024
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the CongoTrésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, et al.
Family Practice|August 27, 2021
Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, BelgiumJoachim Mariën, Ann Ceulemans, Diana Bakokimi, et al.
The Lancet. Infectious Diseases|November 25, 2006
Rotavirus vaccines: considerations for successful implementation in EuropePierre Van Damme, Marie Van der Wielen, Filippo Ansaldi, et al.
International Journal of Cancer|March 19, 2016
Urine testing to monitor the impact of HPV vaccination in Bhutan and RwandaSilvia Franceschi, M Chantal Umulisa, Ugyen Tshomo, et al.
Pageof 37

Showing results (271-280 of 365) with videos related to

Sort By:
Pageof 37
Epidemiology and Infection|August 10, 2021
SARS-CoV-2 seroprevalence survey among health care providers in a Belgian public multiple-site hospitalReinout Naesens, Helena Mertes, Johan Clukers, et al.
The Journal of Infectious Diseases|December 28, 2020
Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in BelgiumElizabeth B Brickley, Ruth I Connor, Wendy Wieland-Alter, et al.
Cell Host & Microbe|April 25, 2020
Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to VirulenceMing Te Yeh, Erika Bujaki, Patrick T Dolan, et al.
Vaccine|March 29, 2014
Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trialsPierre Van Damme, Geert Leroux-Roels, Philippe Simon, et al.
BMJ Global Health|June 29, 2021
Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the CongoGwen Lemey, Ynke Larivière, Trésor Matuvanga Zola, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 11, 2022
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysisArno Verleye, Veerle Wijtvliet, Steven Abrams, et al.
Vaccine|January 1, 2024
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the CongoTrésor Zola Matuvanga, Ynke Larivière, Gwen Lemey, et al.
Family Practice|August 27, 2021
Prospective SARS-CoV-2 cohort study among primary health care providers during the second COVID-19 wave in Flanders, BelgiumJoachim Mariën, Ann Ceulemans, Diana Bakokimi, et al.
The Lancet. Infectious Diseases|November 25, 2006
Rotavirus vaccines: considerations for successful implementation in EuropePierre Van Damme, Marie Van der Wielen, Filippo Ansaldi, et al.
International Journal of Cancer|March 19, 2016
Urine testing to monitor the impact of HPV vaccination in Bhutan and RwandaSilvia Franceschi, M Chantal Umulisa, Ugyen Tshomo, et al.
Pageof 37